Author Page for Usha Menon

Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS

Number of pages: 44 Posted: 22 May 2024

Jacob S. Bedia, Ian J. Jacobs, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Ranjit Manchanda, Jatinderpal K. Kalsi, Anne Dawnay, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Mahesh KB Parmar, Usha Menon and Steven J. Skates

Harvard University - Massachusetts General Hospital, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Queen Mary University of London - Wolfson Institute of Population Health, Imperial College London - AGE Research Unit, University College London, Department of Clinical Biochemistry, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), London School of Economics & Political Science (LSE), Create Health Ltd, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Harvard University - Massachusetts General Hospital

Downloads 123 (584,619)

Abstract:

2.

Immunoaffinity‑Enriched Extracellular Vesicle Proteomics for High‑Grade Serous Ovarian Cancer - A UKOPS Nested Case‑Control Analysis

Number of pages: 36 Posted: 30 Apr 2026

Carlos Salomon, Andrew Lai, Dominic Guanzon, Katherin Scholz-Romero, Nihar Godbole, Carlos Palma, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Gregory E. Rice and Usha Menon

University of Queensland, University of Queensland, University of Queensland, University of Queensland, University of Queensland, INOVIQ Ltd, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University of Queensland and University College London - MRC Clinical Trials Unit

Downloads 114 (630,858)

Abstract:

3.

Why Did Downstaging in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Not Result in a Mortality Benefit: Exploratory Analysis of a Randomised Controlled Trial

Number of pages: 25 Posted: 27 May 2023

Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Andy Ryan, Naveena Singh, Ranjit Manchanda, Jatinderpal K. Kalsi, Robert Woolas, Rupali Arora, Laura Casey, Anne Dawnay, Aarti Sharma, Karin Williamson, Sophia Apostolidou, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Steven J. Skates, Ian J. Jacobs and Mahesh KB Parmar

University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Barts Health NHS Trust, Department of Cellular Pathology, Queen Mary University of London - Wolfson Institute of Population Health, Imperial College London - AGE Research Unit, Government of the United Kingdom - Department of Gynaecological Oncology, University College London - Department of Cellular Pathology, Barts Health NHS Trust, Department of Cellular Pathology, University College London, Department of Clinical Biochemistry, Cardiff and Vale University Health Board - Department of Obstetrics and Gynaecology, University of Nottingham - Department of Gynaecological Oncology, University College London - MRC Clinical Trials Unit, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), London School of Economics & Political Science (LSE), Create Health Ltd, Harvard University - Massachusetts General Hospital, University College London - MRC Clinical Trials Unit and University College London - MRC Clinical Trials Unit

Downloads 74 (844,901)

Abstract:

4.

Extracellular Vesicle and Particle-Based Blood Test for Ovarian Cancer Screening of Average Risk Population: A Promising Nested Case Control Study Using Preclinical Samples

Number of pages: 21 Posted: 22 Aug 2025

Brendan Manning, Sanchari Banerjee, Troy B. Hawkins, Emily S. Winn-Deen, Laura T. Bortolin, Brittany Grimes, Timothy Santos-Heiman, Delaney Bryne, MacKenzie S. King, Daniel P. Salem, Michael Smith, Anthony D. Couvillon, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Steven J. Skates, Christine D. Berg, David F. Ransohoff, Toumy Guettouche, Dawn R. Mattoon and Usha Menon

affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Harvard Medical School, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Harvard University - Massachusetts General Hospital, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - Department of Medicine, Mercy BioAnalytics, affiliation not provided to SSRN and University College London - MRC Clinical Trials Unit

Downloads 37 (1,222,651)

Abstract:

5.

Ovarian Cancer Think Tank: An Overview of the Current Status of Ovarian Cancer Screening and Recommendations for Future Directions

Number of pages: 12 Posted: 28 Feb 2024

Julia Dexter, Lindsay Brubaker, Benjamin G. Bitler, Barbara A. Goff, Usha Menon, Kathleen N. Moore, Karthik M. Sundaram, Christine S. Walsh, Saketh R. Guntupalli and Kian Behbakht

University of Colorado, Aurora, University of Colorado, Aurora, University of Colorado, Aurora - Department of Physiology and Biophysics, University of Washington, University College London - MRC Clinical Trials Unit, University of Oklahoma - Stephenson Cancer Center, University of Pennsylvania, University of Colorado, Aurora, University of Colorado, Aurora and University of Colorado, Aurora

Downloads 35 (1,249,711)

Citation 2

Usha Menon

University College London - MRC Clinical Trials Unit

5

383

2

Scholarly Papers (5)

Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS

Abstract:

Immunoaffinity‑Enriched Extracellular Vesicle Proteomics for High‑Grade Serous Ovarian Cancer - A UKOPS Nested Case‑Control Analysis

Abstract:

Why Did Downstaging in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Not Result in a Mortality Benefit: Exploratory Analysis of a Randomised Controlled Trial

Abstract:

Extracellular Vesicle and Particle-Based Blood Test for Ovarian Cancer Screening of Average Risk Population: A Promising Nested Case Control Study Using Preclinical Samples

Abstract:

Ovarian Cancer Think Tank: An Overview of the Current Status of Ovarian Cancer Screening and Recommendations for Future Directions

Abstract: